Novo Nordisk’s Record Pill Launch Meets a Cybersecurity Reality Check
The Danish drugmaker is living two parallel stories this quarter. One is about the Wayovy pill smashing prescription…
Novo Nordisk’s Pill Breakthrough Meets a Cybersecurity Reality Check
The same week that brought Novo Nordisk a historic regulatory green light for its oral weight-loss pill also…
Novo Nordisk’s AI Search Dominance Faces a Pricing Reality Check
Novo Nordisk’s Wegovy captures 19% of AI chatbot mentions for weight-loss, but adjusted Q1 revenue dropped 4% and…
Novo Nordisk’s Oral GLP-1 Offensive Meets a Wall Street Reality Check
Novo Nordisk faces revenue squeeze as oral Wegovy prescriptions plateau at starter doses, Eli Lilly enters the pill-based…
Q1 Earnings Loom as Valuation Debate Intensifies
Novo Nordisk faces pivotal Q1 earnings amid a 36% YTD stock drop, competitive pressure from Eli Lilly, and…
Novo Nordisk’s AI Bet and High-Dose Launch Face a Revenue Reality Check
Novo Nordisk shares surge on OpenAI partnership and buybacks, but Wall Street is cautious due to sales mix,…
Free LEGO build day to support kids in need
RICHMOND, Va. (WWBT) – Give back this holiday season at the Children’s Museum of Richmond – Chesterfield during…